Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
Chemokines and Leukocyte Trafficking in Homeostasis and Inflammation (2012A1)
Chemokines and Chemokine Receptors (2008J3)

Web Desc
Chemokines and Chemokine Receptors Organizer(s): Andrew Luster and Philip Murphy Date: January 15 - 20, 2006 Location: Snowbird Resort, Snowbird, UT, USA Supported by The Director's Fund Summary of Meeting: Chemokines are chemotactic cytokines that induce the directed migration of cells by activating specific G protein-coupled receptors. This system of ~50 cytokines and ~20 receptors plays a particularly prominent role in development, homeostasis and activation of leukocytes in the mammalian immune system. Chemokines determine the nature of the tissue inflammatory response in a wide range of human diseases and represent attractive new therapeutic targets. Chemokines may also attract and stimulate non-immune cells, such as tumor cells, neurons and blood vessels. This meeting will address major unanswered questions in the chemokine field including how chemokines regulate lymphoid development, how cells sense chemokine gradients, the nature of the chemokine signaling pathway, how chemokines amplify immunologically-mediated disease, and whether disrupting chemokine signaling can treat or prevent disease. A systems biology approach to chemokine function in vivo will be highlighted and will extend to the regulation and interrelationship of the chemokine system with other regulatory systems in vivo. Scholarship Deadline: September 15 2005 Discounted Abstract Deadline: September 15 2005 Abstract Deadline: October 6 2005 Discounted Registration Deadline: November 15 2005 We gratefully acknowledge additional support for this conference from: We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements: EMD Serono, Inc. Merck Research Laboratories We gratefully acknowledge the generous grant for this conference provided by: National Institute of Allergy and Infectious Diseases (NIAID) Grant No. 1 R13 AI066862-01 We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

Chemokines and Chemokine Receptors

Organizer(s): Andrew Luster and Philip Murphy

Date: January 15 - 20, 2006
Location: Snowbird Resort, Snowbird, UT, USA

Supported by The Director's Fund

Summary of Meeting:

Chemokines are chemotactic cytokines that induce the directed migration of cells by activating specific G protein-coupled receptors. This system of ~50 cytokines and ~20 receptors plays a particularly prominent role in development, homeostasis and activation of leukocytes in the mammalian immune system. Chemokines determine the nature of the tissue inflammatory response in a wide range of human diseases and represent attractive new therapeutic targets. Chemokines may also attract and stimulate non-immune cells, such as tumor cells, neurons and blood vessels. This meeting will address major unanswered questions in the chemokine field including how chemokines regulate lymphoid development, how cells sense chemokine gradients, the nature of the chemokine signaling pathway, how chemokines amplify immunologically-mediated disease, and whether disrupting chemokine signaling can treat or prevent disease. A systems biology approach to chemokine function in vivo will be highlighted and will extend to the regulation and interrelationship of the chemokine system with other regulatory systems in vivo.

Scholarship Deadline: September 15 2005

Discounted Abstract Deadline: September 15 2005

Abstract Deadline: October 6 2005

Discounted Registration Deadline: November 15 2005

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

EMD Serono, Inc.

Merck Research Laboratories

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1 R13 AI066862-01

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program


Sunday, January 15 \| 3:00PM - 7:30PM Registration Room: Ballroom Lobby
Sunday, January 15 \| 6:30PM - 7:30PM Refreshments Room: Ballroom Mezzanine & Lobby
Sunday, January 15 \| 7:30PM - 8:30PM Keynote Address Room: Ballroom 2-3 Speaker 1 of 1 Eugene C. Butcher, Stanford University, USA Leukocyte-Endothelial Cell Recognition: Toward a General Model of Leukocyte Trafficking
Monday, January 16 \| 7:00AM - 8:00AM Breakfast Room: Golden Cliff, Wasatch, Superior Lobby
Monday, January 16 \| 8:00AM - 11:30AM Chemokine Control of Leukocyte Trafficking in the Adaptive I mmune Response Room: Ballroom 2-3 Speaker 1 of 8 * Martin Lipp, Max-Delbrueck-Center, MDC, Germany
Monday, January 16 \| 8:00AM - 11:30AM Chemokine Control of Leukocyte Trafficking in the Adaptive I mmune Response Room: Ballroom 2-3 Speaker 2 of 8 Ulrich H. Von Andrian, Harvard Medical School, USA T Cell and DC Trafficking in the Lymph Node
Monday, January 16 \| 8:00AM - 11:30AM Chemokine Control of Leukocyte Trafficking in the Adaptive I mmune Response Room: Ballroom 2-3 Speaker 3 of 8 Reinhold Förster, Hannover Medical School, Germany DC Migraton in Tolerance and Immunity
Monday, January 16 \| 8:00AM - 11:30AM Chemokine Control of Leukocyte Trafficking in the Adaptive I mmune Response Room: Ballroom 2-3 Speaker 4 of 8 Hans-Christian Reinecker, Massachusetts General Hospital, USA Short Talk: Chemokine Receptors Regulate Intestinal DC Subsets in Mucosal Defense
Monday, January 16 \| 8:00AM - 11:30AM Chemokine Control of Leukocyte Trafficking in the Adaptive I mmune Response Room: Ballroom 2-3 Speaker 5 of 8 Federica Sallusto, Università della Svizzera Italiana & ETH Zurich, Switzerland Leukocyte Trafficking to the Inflamed Lymph Node
Monday, January 16 \| 8:00AM - 11:30AM Chemokine Control of Leukocyte Trafficking in the Adaptive I mmune Response Room: Ballroom 2-3 Speaker 6 of 8 Joshua M. Farber, NIAID, National Institutes of Health, USA Chemokines in CD4+ T Cell Memory
Monday, January 16 \| 8:00AM - 11:30AM Chemokine Control of Leukocyte Trafficking in the Adaptive I mmune Response Room: Ballroom 2-3 Speaker 7 of 8 Thomas B. Issekutz, Dalhousie University, Canada Short Talk: Migration of CCR4+ Memory CD4 T Cells to Dermal Inflammation is Mediated by CXCR3
Monday, January 16 \| 8:00AM - 11:30AM Chemokine Control of Leukocyte Trafficking in the Adaptive I mmune Response Room: Ballroom 2-3 Speaker 8 of 8 Hanna Stenstad, Sahlgrenska Academy, Sweden Short Talk: Gut Associated Lymphoid Tissue Primed CD4+ T Cells Display CCR9 Dependent and Independent Homing to the Murine Small Intestine
Monday, January 16 \| 9:20AM - 9:40AM Coffee Break Room: Ballroom Mezzanine & Lobby
Monday, January 16 \| 11:30AM - 1:00PM Poster Setup Room: Superior/Superior Lobby/Maybird
Monday, January 16 \| 1:00PM - 10:00PM Poster Viewing Room: Superior/Superior Lobby/Maybird
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 1 of 10 * Osamu Yoshie, Kinki University, Japan
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 2 of 10 * Joost J. Oppenheim, National Institutes of Health, USA Alarmins are Non-Cognate Chemokine Receptor Ligands and Activators of Dendritic Cells
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 3 of 10 Brigitte Gomperts, University of California, Los Angeles, USA Circulating Progenitor Epithelial Cells Traffic via CXCR4/CXCL12 in Response to Airway Injury
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 4 of 10 Yang Hu, Weill Graduate School of Medical Sciences of Cornell University, USA Costimulation of Chemokine Receptor Signaling by MMP-9 Mediates Enhanced Migration of IFNá-DCs
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 5 of 10 George Ed Rainger, University of Birmingham, UK A Multi-Cellular in Vitro Model of Chronic Inflammatory Joint Disease Identifies Novel Routes of Chemokine Expression Presentation and Function
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 6 of 10 Ewan A. Ross, University of Glasgow, UK Platelet Endothelial Cell Adhesion Molecule (Pecam)-1 Modulates Sdf-1alpha/Cxcr4 Responses of Hematopoietic Stem Cells
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 7 of 10 Marcus Svensson, Lund University, Sweden Role of CCR9 in Thymic T Cell Development
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 8 of 10 Raffaella Bonecchi, Istituto Clinico Humanitas, Italy The Chemokine Decoy Receptor D6 Protects the Fetus from Inflammation Acting as an Inflammatory CC Chemokine Scavenger at the Fetal-Maternal Interface
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 9 of 10 Gabriele S.V. Campanella, Massachusetts General Hospital, USA IP-10 (CXCL10) Oligomerization is Important for its in Vivo Activity
Monday, January 16 \| 2:00PM - 4:30PM Workshop 1: Novel Chemokine Biology Room: Ballroom 2-3 Speaker 10 of 10 Jana Barlic, National Institutes of Health, USA Oxidized LDL Metabolites Upregulate Expression and Function of Monocyte CX3CR1 through a PPARgamma-dependent Pathway
Monday, January 16 \| 4:30PM - 5:00PM Coffee Available Room: Ballroom Mezzanine & Lobby
Monday, January 16 \| 5:00PM - 7:15PM Chemokines in Immune System Homeostasis Room: Ballroom 2-3 Speaker 1 of 6 * Bernhard Moser, Cardiff University School of Medicine, UK Steady-State T Cell Traffick in Human Skin
Monday, January 16 \| 5:00PM - 7:15PM Chemokines in Immune System Homeostasis Room: Ballroom 2-3 Speaker 2 of 6 Mehrdad Matloubian, University of California, San Francisco, USA Regulation of Lymphocyte Exit from Lymphoid Organs
Monday, January 16 \| 5:00PM - 7:15PM Chemokines in Immune System Homeostasis Room: Ballroom 2-3 Speaker 3 of 6 Hugh Rosen, ActivX Biosciences, USA S1P1 Control of Lymphocyte Trafficking
Monday, January 16 \| 5:00PM - 7:15PM Chemokines in Immune System Homeostasis Room: Ballroom 2-3 Speaker 4 of 6 Shannon Bromley, Massachusetts General Hospital, USA Short Talk: CCR7 Guides T Cell Exit from Peripheral Tissues and Entry into Afferent Lymphatic
Monday, January 16 \| 5:00PM - 7:15PM Chemokines in Immune System Homeostasis Room: Ballroom 2-3 Speaker 5 of 6 Ariel Achtman, Max-Delbrück-Centrum für Molekulare Medizin, Germany Short Talk: CCR7 Deficiency Leads to Disturbed Lymphocyte Recirculation through Non-Lymphoid Tissues and Causes Hypertrophic Gastropathy
Monday, January 16 \| 5:00PM - 7:15PM Chemokines in Immune System Homeostasis Room: Ballroom 2-3 Speaker 6 of 6 Shahin Rafii, Weill Cornell Medical College, USA Chemokine-Mediated Interaction of Hematopoietic Progenitors with the Bone Marrow Vascular Niche
Monday, January 16 \| 7:15PM - 8:15PM Social Hour with Lite Bites Room: Superior/Superior Lobby/Maybird
Monday, January 16 \| 7:30PM - 10:00PM Poster Session 1 Room: Superior/Superior Lobby/Maybird
Tuesday, January 17 \| 7:00AM - 8:00AM Breakfast Room: Golden Cliff, Wasatch, Superior Lobby
Tuesday, January 17 \| 8:00AM - 11:15AM Chemoattractant Signal Transduction Room: Ballroom 2-3 Speaker 1 of 7 * Ann Richmond, Vanderbilt University School of Medicine, USA Localiztion of Signaling Events in Chemotaxing
Tuesday, January 17 \| 8:00AM - 11:15AM Chemoattractant Signal Transduction Room: Ballroom 2-3 Speaker 2 of 7 Ronen Alon, Weizmann Institute of Science, Israel Chemokine Regulation of Lymphocyte Adhesion and Migration
Tuesday, January 17 \| 8:00AM - 11:15AM Chemoattractant Signal Transduction Room: Ballroom 2-3 Speaker 3 of 7 Tatsuo Kinashi, Kansai Medical School, Japan Roles of Rap1-RAPL in Chemokine-Mediated Immune Cell Migration
Tuesday, January 17 \| 8:00AM - 11:15AM Chemoattractant Signal Transduction Room: Ballroom 2-3 Speaker 4 of 7 Dianqing Dan Wu, Yale University School of Medicine, USA Genetic Study of Chemoattractant Signaling
Tuesday, January 17 \| 8:00AM - 11:15AM Chemoattractant Signal Transduction Room: Ballroom 2-3 Speaker 5 of 7 Antonella Viola, University of Milan, Italy Orchestration of Leukocyte Chemotaxis by Mitochondrial Dynamics
Tuesday, January 17 \| 8:00AM - 11:15AM Chemoattractant Signal Transduction Room: Ballroom 2-3 Speaker 6 of 7 Jens V. Stein, University of Bern, Switzerland Short Talk: A Central Role for DOCK2 During Interstitial T and B Lymphocyte Migration and Lymph Node Egress
Tuesday, January 17 \| 8:00AM - 11:15AM Chemoattractant Signal Transduction Room: Ballroom 2-3 Speaker 7 of 7 Barbara Walzog, Ludwig-Maximilians-Universität, Germany Short Talk: The Vav Binding Site of the Non-Receptor Tyrosine Kinase Syk at Tyr 348 Is Critical for Beta2 Integrin (CD11/CD18)-Mediated Leukocyte Polarization and Migration
Tuesday, January 17 \| 9:20AM - 9:40AM Coffee Break Room: Ballroom Mezzanine & Lobby
Tuesday, January 17 \| 11:30AM - 1:00PM Poster Setup Room: Superior/Superior Lobby/Maybird
Tuesday, January 17 \| 1:00PM - 10:00PM Poster Viewing Room: Superior/Superior Lobby/Maybird
Tuesday, January 17 \| 4:30PM - 5:00PM Coffee Available Room: Ballroom Mezzanine & Lobby
Tuesday, January 17 \| 5:00PM - 7:15PM Regulation of Chemokine Action Room: Ballroom 2-3 Speaker 1 of 5 * Gerry J. Graham, University of Glasgow, UK The Chemokine Decoy Receptor, D6, Regulates the Inflammatory Response in vivo
Tuesday, January 17 \| 5:00PM - 7:15PM Regulation of Chemokine Action Room: Ballroom 2-3 Speaker 2 of 5 Frances E. Lund, University of Alabama at Birmingham, USA Regulation of Cell Trafficking under Homeostatic and Inflammatory Conditions: Roles for CD38, cADPR and Galphaq
Tuesday, January 17 \| 5:00PM - 7:15PM Regulation of Chemokine Action Room: Ballroom 2-3 Speaker 3 of 5 Christopher M. Overall, University of British Columbia, Canada Dynamic Regulation of the Chemokine Web by Matrix Metalloproteinases
Tuesday, January 17 \| 5:00PM - 7:15PM Regulation of Chemokine Action Room: Ballroom 2-3 Speaker 4 of 5 Ifor Williams, Science Immunology, USA Short Talk: Developmental Regulation of Sulfation of N-Terminal Tyrosine of Mouse CCR9 by Tyrsoylprotein Sulfotransferase-2
Tuesday, January 17 \| 5:00PM - 7:15PM Regulation of Chemokine Action Room: Ballroom 2-3 Speaker 5 of 5 Andrea Meiser, Imperial College, Faculty of Medicine, UK Short Talk: The Chemokine Receptor CXCR3 is Replenished at the Cell Surface by de novo Synthesis of Receptor and not by Receptor Recycling
Tuesday, January 17 \| 7:15PM - 8:15PM Social Hour with Lite Bites Room: Superior/Superior Lobby/Maybird
Tuesday, January 17 \| 7:30PM - 10:00PM Poster Session 2 Room: Superior/Superior Lobby/Maybird
Wednesday, January 18 \| 7:00AM - 8:00AM Breakfast Room: Golden Cliff, Wasatch, Superior Lobby
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 1 of 9 * Richard M. Ransohoff, Third Rock Ventures, USA EAE in D6-/- Mice
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 2 of 9 Klaus Ley, La Jolla Institute for Allergy and Immunology, USA Arrest Chemokines in Atherosclerosis: Specialized Receptors and Signaling Pathways
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 3 of 9 Seema S. Ahuja, University of Texas Health Science Center, USA Chemokines and Chemokine Receptors in Rheumatoid Arthritis
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 4 of 9 Thomas J. Schall, ChemoCentryx, Inc., USA Novel Chemokines and Chemokine Receptors in Development and Disease
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 5 of 9 Israel F. Charo, ChemoCentryx, Inc., USA Chemokines and the Metabolic Syndrome
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 6 of 9 Robert E. Gerszten, Beth Israel Deaconess Medical Center, USA Short Talk: The T Cell Chemokine CXCL10 (IP-10) Modulates Atherogenesis via the Local Balance of the Effector and Regulatory Arms of the Immune System
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 7 of 9 Nikolaos G. Frangogiannis, Baylor College of Medicine, USA Short Talk: Role of the C-C Chemokines in Myocardial Infarction
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 8 of 9 Amnon Peled, Hebrew University, Israel Role of Chemokine Receptors in NK Cell Mobilization and Trafficking
Wednesday, January 18 \| 8:00AM - 11:30AM Chemokines in Immunologically-Mediated Disease I Room: Ballroom 2-3 Speaker 9 of 9 Toshihiro Nanki, Teikyo University, Japan Short Talk: Pathogenic Role of CXCL16-CXCR6 Pathway in Rheumatoid Arthritis
Wednesday, January 18 \| 9:20AM - 9:40AM Coffee Break Room: Ballroom Mezzanine & Lobby
Wednesday, January 18 \| 11:00AM - 1:00PM Poster Setup Room: Superior/Superior Lobby/Maybird
Wednesday, January 18 \| 1:00PM - 10:00PM Poster Viewing Room: Superior/Superior Lobby/Maybird
Wednesday, January 18 \| 4:30PM - 5:00PM Coffee Available Room: Ballroom Mezzanine & Lobby
Wednesday, January 18 \| 5:00PM - 7:30PM Chemokines in Immunologically-Mediated Disease II Room: Ballroom 2-3 Speaker 1 of 7 * Craig Gerard, Children's Hospital Harvard University, USA
Wednesday, January 18 \| 5:00PM - 7:30PM Chemokines in Immunologically-Mediated Disease II Room: Ballroom 2-3 Speaker 2 of 7 Nicholas W. Lukacs, University of Michigan, USA Chemokine Receptors and Chronic Airway Disease
Wednesday, January 18 \| 5:00PM - 7:30PM Chemokines in Immunologically-Mediated Disease II Room: Ballroom 2-3 Speaker 3 of 7 Dan R. Littman, HHMI/New York University School of Medicine, USA Chemokines in Myeloid and T Cell Function
Wednesday, January 18 \| 5:00PM - 7:30PM Chemokines in Immunologically-Mediated Disease II Room: Ballroom 2-3 Speaker 4 of 7 Richard M. Ransohoff, Third Rock Ventures, USA
Wednesday, January 18 \| 5:00PM - 7:30PM Chemokines in Immunologically-Mediated Disease II Room: Ballroom 2-3 Speaker 5 of 7 Joseph El Khoury, Massachusetts General Hospital, USA Short Talk: Chemokine Regulation of Microglial Recruitment in Alzheimer's Disease
Wednesday, January 18 \| 5:00PM - 7:30PM Chemokines in Immunologically-Mediated Disease II Room: Ballroom 2-3 Speaker 6 of 7 Jesús Rivera-Nieves, Inflammatory Bowel Disease Center, USA Short Talk: Role of CCR9/CCL25 in Chronic Murine Ileitis
Wednesday, January 18 \| 5:00PM - 7:30PM Chemokines in Immunologically-Mediated Disease II Room: Ballroom 2-3 Speaker 7 of 7 Julie A. DeMartino, EMD Serono Research & Development Institute, Inc., USA Updates and Future Directions of Anti-Chemokine Therapeutics
Wednesday, January 18 \| 7:15PM - 8:15PM Social Hour with Lite Bites Room: Superior/Superior Lobby/Maybird
Wednesday, January 18 \| 7:30PM - 10:00PM Poster Session 3 Room: Superior/Superior Lobby/Maybird
Thursday, January 19 \| 7:00AM - 8:00AM Breakfast Room: Golden Cliff, Wasatch, Superior Lobby
Thursday, January 19 \| 8:00AM - 11:30AM Chemokines and Infectious Disease Room: Ballroom 2-3 Speaker 1 of 8 * Steven L. Kunkel, University of Michigan Medical School, USA
Thursday, January 19 \| 8:00AM - 11:30AM Chemokines and Infectious Disease Room: Ballroom 2-3 Speaker 2 of 8 Antonio Alcami, Centro de Biologia Molecular Severo Ochoa, Spain Viral Chemokine Binding Proteins
Thursday, January 19 \| 8:00AM - 11:30AM Chemokines and Infectious Disease Room: Ballroom 2-3 Speaker 3 of 8 Eric G. Pamer, University of Chicago, USA Regulation of Leukocyte Trafficking during Infection
Thursday, January 19 \| 8:00AM - 11:30AM Chemokines and Infectious Disease Room: Ballroom 2-3 Speaker 4 of 8 Kouji Matsushima, University of Tokyo School of Medicine, Japan Chemokine-Regulated Subsets of DCs in Anti-Viral Immunity
Thursday, January 19 \| 8:00AM - 11:30AM Chemokines and Infectious Disease Room: Ballroom 2-3 Speaker 5 of 8 Michael J. Holtzman, Washington University in St. Louis, USA Chemokine Protection from Virus-Induced Cell Death
Thursday, January 19 \| 8:00AM - 11:30AM Chemokines and Infectious Disease Room: Ballroom 2-3 Speaker 6 of 8 Jean K. Lim, Icahn School of Medicine at Mount Sinai, USA Short Talk: Chemokine Receptor CCR5 Mediates Resistance to West Nile Virus Infection in Mouse and Man
Thursday, January 19 \| 8:00AM - 11:30AM Chemokines and Infectious Disease Room: Ballroom 2-3 Speaker 7 of 8 Fang Liao, Academia Sinica, Taiwan Short Talk: Both CXCR3 and CXCL10/IP-10 are Required for Resistance to Primary Infection by Dengue Virus
Thursday, January 19 \| 8:00AM - 11:30AM Chemokines and Infectious Disease Room: Ballroom 2-3 Speaker 8 of 8 Kathleen Kelly, University of California Los Angeles, USA Short Talk: CXCL13 is Induced within Human Fallopian Tubes Following Infection with Chlamydia and Alters Oviduct Pathology
Thursday, January 19 \| 9:20AM - 9:40AM Coffee Break Room: Ballroom Mezzanine & Lobby
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 1 of 10 * Amanda E.I. Proudfoot Fichard, Merck Serono Geneva Research Centre, Switzerland
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 2 of 10 * Albert Zlotnik, University of California Irvine, USA Diagnostic and Therapeutic Uses of Chemokines
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 3 of 10 Andreas J. Kungl, ProtAffin Biotechnologie AG, Austria Developing Receptor-Deficient Chemokine Mutants Towards Glycosaminoglycan Antagonists: The CellJammer Anti-Inflammatory Approach
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 4 of 10 Andrea Martin, Eli Lilly and Company, USA The Chemokine Binding Protein M3 Prevents Inflammatory and Autoimmune Diabetes
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 5 of 10 Christina Anne Bursill, Heart Reserach Institute, Australia Membrane-Bound CC-Chemokine Inhibitor ‘M35K’ Provides Localised Inhibition of CC-Chemokine Activity in Vitro and in Vivo
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 6 of 10 Jen Alexander-Brett, Washington University, USA Promiscuous Chemokine Sequestration By a Herpesvirus Decoy Receptor
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 7 of 10 R. William Hipkin, Schering-Plough Research Institute, USA The Affinity and Intrinsic Activity of Chemokines at hCXCR1 and hCSCR2: CXCL8 is Functionally CXCR1-Selective
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 8 of 10 Kathleen A. Sullivan, Merck & Co., Inc., USA In Vivo Consequences of CXCR3 Blockade with Small Molecule Antagonists
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 9 of 10 Kenneth R. Cooke, Johns Hopkins, USA CCR1:CCL5 (RANTES) Receptor:Ligand Interactions Modulate Allogeneic T Cell Responses Following Allogeneic Bone Marrow Transplantation
Thursday, January 19 \| 2:00PM - 4:30PM Workshop 2: Preclinical and Clinical Development of Anti-Che mokine Therapy for Disease Room: Ballroom 2-3 Speaker 10 of 10 Oliver Dewald, Klinikum Oldenburg, Germany CCL2/MCP-1 Deficiency Prevents Development of Ischemic Cardiomyopathy Decreasing Interstitial Fibrosis
Thursday, January 19 \| 4:30PM - 5:00PM Coffee Available Room: Ballroom Mezzanine & Lobby
Thursday, January 19 \| 5:00PM - 7:15PM Chemokines in Cancer and Development Room: Ballroom 2-3 Speaker 1 of 6 * Robert M. Strieter, University of Virginia School of Medicine, USA Chemokines and Cancer
Thursday, January 19 \| 5:00PM - 7:15PM Chemokines in Cancer and Development Room: Ballroom 2-3 Speaker 2 of 6 Fabienne Mackay, Monash University, Australia CXCR7 Deficient Mice Reveal a Key Role for this Receptor in Cardiac Development and Splenic Marginal Zone B Cell Formation
Thursday, January 19 \| 5:00PM - 7:15PM Chemokines in Cancer and Development Room: Ballroom 2-3 Speaker 3 of 6 Tyler J. Curiel, University of Texas Health, USA Chemokines in Cancer Pathogenesis
Thursday, January 19 \| 5:00PM - 7:15PM Chemokines in Cancer and Development Room: Ballroom 2-3 Speaker 4 of 6 Sergio A. Lira, Mount Sinai School of Medicine, USA Tumorigenesis Induced by the HHV8-Encoded Chemokine Receptor
Thursday, January 19 \| 5:00PM - 7:15PM Chemokines in Cancer and Development Room: Ballroom 2-3 Speaker 5 of 6 Gwendal Lazennec, INSERM, France Short Talk: IL-8 is a Novel Marker for Breast Cancer
Thursday, January 19 \| 5:00PM - 7:15PM Chemokines in Cancer and Development Room: Ballroom 2-3 Speaker 6 of 6 Hiroshi Miyazaki, Philips Institute-Virginia Commonwealth University, USA Short Talk: Regulation of Squamous Cell Carcinoma Proliferation and Invasion by CXCL5
Thursday, January 19 \| 7:15PM - 8:15PM Social Hour with Lite Bites Room: Golden Cliff, Eagles Nest, Superior Lobby
Thursday, January 19 \| 8:00PM - 11:00PM Entertainment Room: Golden Cliff, Eagles Nest, Superior Lobby
Thursday, January 19 \| 8:15PM - 11:00PM Cash Bar Room: Golden Cliff, Eagles Nest, Superior Lobby
Friday, January 20 \| 10:26AM - 10:26AM Departure *Session Chair.